Filter
151
Text search:
vaccine
vial
monitor
Featured
Recommendations
23
New Publications
49
Language
Document type
No document type
71
Guidelines
40
Manuals
12
Fact sheets
9
Studies & Reports
7
Strategic & Response Plan
7
Training Material
2
Situation Updates
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
15
South Africa
6
Uganda
5
Kenya
4
Tanzania
4
Africa
4
Global
4
Ethiopia
3
Rwanda
3
Sierra Leone
2
Liberia
2
Senegal
2
Philippines
2
Nepal
2
Myanmar / Burma
2
Latin America and the Carribbean
2
Guinea
1
Burkina Faso
1
Nigeria
1
Congo, Democratic Republic of
1
Mali
1
Guinea-Bissau
1
Cameroon
1
Zimbabwe
1
South Sudan
1
Afghanistan
1
Zambia
1
Syria
1
Bangladesh
1
Malawi
1
Central African Republic
1
Namibia
1
Yemen
1
West and Central Africa
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
55
Clinical Guidelines
29
Women & Child Health
15
Public Health
8
Capacity Building
2
Pharmacy & Technologies
1
Toolboxes
COVID-19
33
Rapid Response
10
Pharmacy
10
Polio
7
AMR
4
Caregiver
4
Ebola
2
Cholera
2
Conflict
2
TB
2
NTDs
2
Natural Hazards
1
Refugee
1
Zika
1
Mental Health
1
NCDs
1
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary include
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the back
...
Accessed Sept, 5 2018
Weekly epidemiological record, Relevé épidémiologique hebdomadaire : Vol.93 (2018) No.13
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01
...
Humanitarian emergencies, regardless of type and cause, have a number of common risk factors for communicable diseases inextricably linked to excess risk of morbidity and mortality which can come from vaccine–preventable diseases (VPDs). The reduc
...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and a
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the b
...
Working Document Nov. 2020
The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vaccination, Country Readiness & Delivery: Supply and Logistics Guidance. Countries might find this Guide useful when developing and strengthening their sup
...
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 29 JULY 2016, 91th YEAR / 29 JUILLET 2016, 91e ANNÉENo 30, 2016, 91, 349–364
A handbook for district and health facility staff
first issued 18 August 2022
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a
...
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
The Regional strategy for measles control recommends that a second opportunity for measles immunization be provided to all children irrespective of their vaccination status or history of clinical measles. The preferred method of provision of a second opportunity is through Supplemental Immunization
...
A handbook for district and health facility staff
The EYE strategy is a comprehensive and long-term strategy built on lessons learned that aims at ending yellow fever epidemics by 2026, and consists of three strategic objectives:
protect at-risk populations;
prevent international spread; and
contain outbreaks rapidly.
